- Home
- AGI vs TFX Comparison
AGI vs TFX Comparison
Compare AGI & TFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGI
- TFX
- Stock Information
- Founded
- AGI 2003
- TFX 1943
- Country
- AGI Canada
- TFX United States
- Employees
- AGI N/A
- TFX N/A
- Industry
- AGI Precious Metals
- TFX Medical/Dental Instruments
- Sector
- AGI Basic Materials
- TFX Health Care
- Exchange
- AGI Nasdaq
- TFX Nasdaq
- Market Cap
- AGI 7.6B
- TFX 8.4B
- IPO Year
- AGI 1999
- TFX N/A
- Fundamental
- Price
- AGI $18.32
- TFX $178.17
- Analyst Decision
- AGI Strong Buy
- TFX Buy
- Analyst Count
- AGI 5
- TFX 8
- Target Price
- AGI $22.25
- TFX $255.14
- AVG Volume (30 Days)
- AGI 2.3M
- TFX 499.0K
- Earning Date
- AGI 02-19-2025
- TFX 02-20-2025
- Dividend Yield
- AGI 0.55%
- TFX 0.76%
- EPS Growth
- AGI 18.31
- TFX N/A
- EPS
- AGI 0.60
- TFX 5.03
- Revenue
- AGI $1,225,700,000.00
- TFX $3,025,824,000.00
- Revenue This Year
- AGI $33.98
- TFX $4.52
- Revenue Next Year
- AGI $20.42
- TFX $4.86
- P/E Ratio
- AGI $31.54
- TFX $35.35
- Revenue Growth
- AGI 22.50
- TFX 2.27
- 52 Week Low
- AGI $11.24
- TFX $171.69
- 52 Week High
- AGI $21.45
- TFX $256.85
- Technical
- Relative Strength Index (RSI)
- AGI 42.32
- TFX 34.88
- Support Level
- AGI $17.95
- TFX $171.69
- Resistance Level
- AGI $20.45
- TFX $188.87
- Average True Range (ATR)
- AGI 0.60
- TFX 4.78
- MACD
- AGI -0.10
- TFX 0.13
- Stochastic Oscillator
- AGI 14.80
- TFX 27.52
About AGI Alamos Gold Inc.
Alamos Gold Inc acquires, explores, and produces gold and other precious metals, and operates in two principal geographic areas: Canada and Mexico. The company has three operating mines in North America: Young-Davidson and Island Gold mines operate in Canada and the Mulatos and in Sonora, Mexico. The company generates maximum revenue from the Mulatos mines.
About TFX Teleflex Incorporated
Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2023 sales), interventional (17%), anesthesia (13%), surgical (14%), interventional urology (11%), original-equipment manufacturing (11%), and other (10%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.